Financhill
Buy
54

TGT Quote, Financials, Valuation and Earnings

Last price:
$97.76
Seasonality move :
18.11%
Day range:
$97.20 - $98.44
52-week range:
$83.44 - $145.08
Dividend yield:
4.62%
P/E ratio:
11.86x
P/S ratio:
0.42x
P/B ratio:
2.86x
Volume:
4.3M
Avg. volume:
7.9M
1-year change:
-27.69%
Market cap:
$44.3B
Revenue:
$106.6B
EPS (TTM):
$8.24
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Revenue $93.6B $106B $109.1B $107.4B $106.6B
Revenue Growth (YoY) 19.78% 13.3% 2.94% -1.57% -0.79%
 
Cost of Revenues $68.2B $77.3B $84.6B $80.2B $79B
Gross Profit $25.4B $28.7B $24.5B $27.3B $27.5B
Gross Profit Margin 27.13% 27.07% 22.46% 25.38% 25.84%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.6B $19.8B $20.7B $21.6B $22B
Other Inc / (Exp) -$16M $382M $48M $92M $106M
Operating Expenses $18.6B $19.7B $20.6B $21.5B $21.9B
Operating Income $6.8B $9B $3.9B $5.8B $5.6B
 
Net Interest Expenses $465M $421M $482M $526M $434M
EBT. Incl. Unusual Items $5.5B $8.9B $3.4B $5.3B $5.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2B $2B $638M $1.2B $1.2B
Net Income to Company $4.4B $6.9B $2.8B $4.1B $4.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.4B $6.9B $2.8B $4.1B $4.1B
 
Basic EPS (Cont. Ops) $8.73 $14.23 $6.02 $8.97 $8.89
Diluted EPS (Cont. Ops) $8.64 $14.10 $5.98 $8.94 $8.86
Weighted Average Basic Share $500.6M $488.1M $462.1M $461.5M $460.4M
Weighted Average Diluted Share $505.4M $492.7M $464.7M $462.8M $461.8M
 
EBITDA $9.3B $11.7B $6.6B $8.6B $8.6B
EBIT $6.8B $9B $3.9B $5.8B $5.6B
 
Revenue (Reported) $93.6B $106B $109.1B $107.4B $106.6B
Operating Income (Reported) $6.8B $9B $3.9B $5.8B $5.6B
Operating Income (Adjusted) $6.8B $9B $3.9B $5.8B $5.6B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $25.7B $26.5B $25.4B $25.7B $25.3B
Revenue Growth (YoY) 13.34% 3.38% -4.22% 1.06% -1.55%
 
Cost of Revenues $18.8B $20.3B $18.8B $19B $18.8B
Gross Profit $6.9B $6.2B $6.6B $6.7B $6.5B
Gross Profit Margin 26.78% 23.54% 26.12% 25.92% 25.66%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9B $5.2B $5.3B $5.5B $5.5B
Other Inc / (Exp) $6M $12M $25M $28M --
Operating Expenses $4.9B $5.2B $5.3B $5.5B $5.5B
Operating Income $2B $1B $1.4B $1.2B $983M
 
Net Interest Expenses $105M $125M $113M $111M $121M
EBT. Incl. Unusual Items $1.9B $909M $1.2B $1.1B $859M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $423M $197M $264M $237M $170M
Net Income to Company $1.5B $712M $971M $854M $689M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.5B $712M $971M $854M $689M
 
Basic EPS (Cont. Ops) $3.07 $1.55 $2.10 $1.86 $1.52
Diluted EPS (Cont. Ops) $3.04 $1.54 $2.10 $1.85 $1.51
Weighted Average Basic Share $484.8M $460.3M $461.6M $460.1M $453.7M
Weighted Average Diluted Share $489.4M $462.5M $462.6M $461.5M $455.1M
 
EBITDA $2.7B $1.7B $2.1B $1.9B $1.8B
EBIT $2B $1B $1.4B $1.2B $983M
 
Revenue (Reported) $25.7B $26.5B $25.4B $25.7B $25.3B
Operating Income (Reported) $2B $1B $1.4B $1.2B $983M
Operating Income (Adjusted) $2B $1B $1.4B $1.2B $983M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $103.3B $108.7B $106.9B $107.6B $105.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $74.8B $83.4B $80.7B $79.5B $78.6B
Gross Profit $28.6B $25.3B $26.2B $28B $26.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $19.7B $20.5B $21.2B $22.1B $21.5B
Other Inc / (Exp) $356M $61M $77M $105M --
Operating Expenses $19.6B $20.5B $21.1B $22B $21.4B
Operating Income $9B $4.8B $5.1B $6B $5.3B
 
Net Interest Expenses $317M $453M $546M $452M $460M
EBT. Incl. Unusual Items $8.6B $4.4B $4.6B $5.6B $4.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.8B $944M $922M $1.3B $1.1B
Net Income to Company $6.8B $3.4B $3.6B $4.4B $3.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.8B $3.4B $3.6B $4.4B $3.8B
 
Basic EPS (Cont. Ops) $13.72 $7.36 $7.88 $9.46 $8.27
Diluted EPS (Cont. Ops) $13.59 $7.30 $7.85 $9.44 $8.24
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $11.6B $7.5B $7.9B $8.9B $8.4B
EBIT $9B $4.8B $5.1B $6B $5.3B
 
Revenue (Reported) $103.3B $108.7B $106.9B $107.6B $105.2B
Operating Income (Reported) $9B $4.8B $5.1B $6B $5.3B
Operating Income (Adjusted) $9B $4.8B $5.1B $6B $5.3B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $75B $77.7B $75.5B $75.7B $74.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $53.7B $60.1B $56.1B $55.5B $55.1B
Gross Profit $21.3B $17.7B $19.4B $20.1B $19.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.2B $15B $15.5B $16B $15.5B
Other Inc / (Exp) $356M $35M $64M $77M $26M
Operating Expenses $14.1B $14.9B $15.4B $16B $15.4B
Operating Income $7.2B $2.7B $3.9B $4.1B $3.8B
 
Net Interest Expenses $317M $349M $413M $339M $365M
EBT. Incl. Unusual Items $6.9B $2.4B $3.5B $3.9B $3.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.5B $471M $755M $867M $799M
Net Income to Company $5.4B $1.9B $2.8B $3B $2.7B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.4B $1.9B $2.8B $3B $2.7B
 
Basic EPS (Cont. Ops) $10.96 $4.12 $5.97 $6.47 $5.85
Diluted EPS (Cont. Ops) $10.86 $4.09 $5.96 $6.45 $5.84
Weighted Average Basic Share $1.5B $1.4B $1.4B $1.4B $1.4B
Weighted Average Diluted Share $1.5B $1.4B $1.4B $1.4B $1.4B
 
EBITDA $9.1B $4.7B $6B $6.4B $6.1B
EBIT $7.2B $2.7B $3.9B $4.1B $3.8B
 
Revenue (Reported) $75B $77.7B $75.5B $75.7B $74.3B
Operating Income (Reported) $7.2B $2.7B $3.9B $4.1B $3.8B
Operating Income (Adjusted) $7.2B $2.7B $3.9B $4.1B $3.8B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Cash and Equivalents $8.5B $5.9B $2.2B $3.8B $4.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $504M $518M $526M $513M $543M
Inventory $10.7B $13.9B $13.5B $11.9B $12.7B
Prepaid Expenses $171M $170M $188M $201M $226M
Other Current Assets $286M $237M $235M $202M $185M
Total Current Assets $20.8B $21.6B $17.8B $17.5B $19.5B
 
Property Plant And Equipment $29.1B $30.7B $34.2B $36.5B $36.8B
Long-Term Investments $638M $605M $447M $483M $540M
Goodwill $631M -- -- $631M $631M
Other Intangibles $37M -- -- -- --
Other Long-Term Assets $268M $375M $160M $229M $238M
Total Assets $51.2B $53.8B $53.3B $55.4B $57.8B
 
Accounts Payable $10.9B $12.9B $11.9B $10.5B $13.1B
Accrued Expenses $1.8B $1.7B $1.4B $1.7B $1.7B
Current Portion Of Long-Term Debt $1.1B $171M $130M $1.1B $1.6B
Current Portion Of Capital Lease Obligations $211M $254M $296M $329M $353M
Other Current Liabilities $2.5B $1.3B $1.5B $1.3B $1.1B
Total Current Liabilities $20.1B $21.7B $19.5B $19.3B $20.8B
 
Long-Term Debt $13.8B $16B $18.6B $18.2B $17.9B
Capital Leases -- -- -- -- --
Total Liabilities $36.8B $41B $42.1B $41.9B $43.1B
 
Common Stock $42M $39M $38M $38M $38M
Other Common Equity Adj -$756M -$553M -$419M -$460M -$458M
Common Equity $14.4B $12.8B $11.2B $13.4B $14.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $14.4B $12.8B $11.2B $13.4B $14.7B
 
Total Liabilities and Equity $51.2B $53.8B $53.3B $55.4B $57.8B
Cash and Short Terms $8.5B $5.9B $2.2B $3.8B $4.8B
Total Debt $14.9B $16.2B $18.8B $19.3B $19.5B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Cash and Equivalents $5.8B $954M $1.9B $3.4B $3.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory $15B $17.1B $14.7B $15.2B $14.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.9B $2.3B $2B $2B --
Total Current Assets $22.6B $20.4B $18.6B $20.6B $20.7B
 
Property Plant And Equipment $30.5B $33.5B $36.3B $36.4B $37.4B
Long-Term Investments $116M $341M -- -- $2M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.4B $1.7B $1.4B $1.5B --
Total Assets $54.4B $55.6B $56.2B $58.5B $60B
 
Accounts Payable $16.3B $15.4B $14.3B $14.4B $13.8B
Accrued Expenses $5.9B $6.1B $6.1B $5.7B --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $23.4B $23.8B $21.5B $21.8B $21.2B
 
Long-Term Debt $14.1B $16.8B $17.9B $17.8B $18.9B
Capital Leases -- -- -- -- --
Total Liabilities $40.6B $44.6B $43.7B $44B $44.5B
 
Common Stock $40M $38M $38M $38M $38M
Other Common Equity Adj -$687M -$208M -$430M -$474M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $13.8B $11B $12.5B $14.5B $15.5B
 
Total Liabilities and Equity $54.4B $55.6B $56.2B $58.5B $60B
Cash and Short Terms $5.8B $954M $1.9B $3.4B $3.8B
Total Debt $15.3B $16.9B $19B $19.4B $20B
Period Ending 2021-01-31 2022-01-31 2023-01-31 2024-01-31 2025-01-31
Net Income to Stockholders $4.4B $6.9B $2.8B $4.1B $4.1B
Depreciation & Amoritzation $2.5B $2.6B $2.7B $2.8B $3B
Stock-Based Compensation $200M $228M $220M $251M $304M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$1.7B -$3.2B $403M $1.6B -$854M
Cash From Operations $10.5B $8.6B $4B $8.6B $7.4B
 
Capital Expenditures $2.6B $3.5B $5.5B $4.8B $2.9B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.6B -$3.2B -$5.5B -$4.8B -$2.9B
 
Dividends Paid (Ex Special Dividend) $1.3B $1.5B $1.8B $2B $2B
Special Dividend Paid
Long-Term Debt Issued $2.5B $2B $2.6B -- $741M
Long-Term Debt Repaid -$2.4B -$1.1B -$163M -$147M -$1.1B
Repurchase of Common Stock $745M $7.4B $2.8B -- $1B
Other Financing Activities -- -$168M -$180M -$127M -$99M
Cash From Financing -$2B -$8.1B -$2.2B -$2.3B -$3.6B
 
Beginning Cash (CF) $867M $926M $886M $908M $869M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.9B -$2.6B -$3.7B $1.6B $957M
Ending Cash (CF) $6.8B -$1.7B -$2.8B $2.5B $1.8B
 
Levered Free Cash Flow $7.9B $5.1B -$1.5B $3.8B $4.5B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $1.5B $712M $971M $854M $689M
Depreciation & Amoritzation $652M $675M $722M $754M $773M
Stock-Based Compensation $49M $55M $69M $80M $64M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$3.7B -$1.8B -$2B -$2.6B -$2B
Cash From Operations $2.2B $599M $1.9B $739M $1.1B
 
Capital Expenditures $1.1B $1.8B $1.1B $655M $978M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1B -$1.8B -$1.1B -$637M -$937M
 
Dividends Paid (Ex Special Dividend) $440M $497M $507M $516M $518M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $3.1B -- $741M --
Long-Term Debt Repaid -$40M -$26M -$42M -$36M --
Repurchase of Common Stock $2.2B $4M -- $351M $150M
Other Financing Activities -- -$4M -$3M -$4M --
Cash From Financing -$2.7B $1B -$552M -$166M -$709M
 
Beginning Cash (CF) $935M $954M $1.9B $977M $928M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.6B -$163M $293M -$64M -$519M
Ending Cash (CF) -$680M $791M $2.2B $913M $409M
 
Levered Free Cash Flow $1B -$1.2B $807M $84M $149M
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $6.8B $3.4B $3.6B $4.4B $3.8B
Depreciation & Amoritzation $2.6B $2.7B $2.8B $2.9B $3.1B
Stock-Based Compensation $226M $218M $219M $304M $272M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$2.2B -$2.2B $2.4B -$434M $269M
Cash From Operations $9.1B $3.6B $8.8B $7.4B $6.8B
 
Capital Expenditures $3.1B $5.4B $5.2B $2.8B $3.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.7B -$5.4B -$5.1B -$2.8B -$3.7B
 
Dividends Paid (Ex Special Dividend) $1.5B $1.8B $2B $2B $2.1B
Special Dividend Paid
Long-Term Debt Issued -- $5.1B -- -- --
Long-Term Debt Repaid -$132M -$1.2B -$138M -$1.1B --
Repurchase of Common Stock $5B $5.1B $1M $506M $909M
Other Financing Activities -- -- -$125M -$101M --
Cash From Financing -$6.6B -$3B -$2.7B -$3.1B -$2.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$243M -$4.8B $956M $1.5B $389M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6B -$1.8B $3.6B $4.5B $3B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $5.4B $1.9B $2.8B $3B $2.7B
Depreciation & Amoritzation $2B $2B $2.1B $2.2B $2.3B
Stock-Based Compensation $187M $177M $176M $229M $197M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$4.3B -$3.2B -$1.2B -$3.3B -$2.2B
Cash From Operations $5.6B $552M $5.3B $4.1B $3.5B
 
Capital Expenditures $2.5B $4.3B $4B $2B $2.8B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.1B -$4.3B -$3.9B -$1.9B -$2.8B
 
Dividends Paid (Ex Special Dividend) $1.1B $1.3B $1.5B $1.5B $1.5B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $3.1B -- $741M $991M
Long-Term Debt Repaid -$112M -$139M -$114M -$1.1B -$1.5B
Repurchase of Common Stock $5B $2.8B -- $506M $408M
Other Financing Activities -- -$179M -$124M -$98M -$60M
Cash From Financing -$6.3B -$1.2B -$1.7B -$2.5B -$1.6B
 
Beginning Cash (CF) $2.8B $3B $3.7B $2.9B $2.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.8B -$5B -$319M -$372M -$940M
Ending Cash (CF) $27M -$2B $3.4B $2.5B $1.9B
 
Levered Free Cash Flow $3.1B -$3.8B $1.4B $2.1B $643M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Buy
81
ZIJMY alert for Jan 1

Zijin Mining Group Co., Ltd. [ZIJMY] is up 1.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock